MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition

키워드

참고문헌 (31)

1. Chiu WT, "FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells", Oncotarget, 6, pp.2349~2365 (2015)
2. Kuchenbaecker KB, "Identification of six new susceptibility loci for invasive epithelial ovarian cancer", Nat Genet, 47, pp.164~171 (2015)[DOI]
3. Raghavan R, "Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer", BMC Genomics, 17, pp.811~ (2016)[DOI]
4. Siddik ZH, "Cisplatin: mode of cytotoxic action and molecular basis of resistance", Oncogene, 22, pp.7265~7279 (2003)[DOI]
5. Zamble DB, "Cisplatin and DNA repair in cancer chemotherapy", Trends Biochem Sci, 20, pp.435~439 (1995)[DOI]
6. Siegel R, "Cancer statistics for Hispanics", Latinos, 2012, 2012, pp.62, 283~298
7. Polyak K, "Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits", Nat Rev Cancer, 9, pp.265~273 (2009)[DOI]
8. Marchini S, "Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer", Eur J Cancer, 49, pp.520~530 (2013)[DOI]
9. Calin GA, "MicroRNA signatures in human cancers", Nat Rev Cancer, 6, pp.857~866 (2006)[DOI]
10. Chang TC, "Widespread microRNA repression by Myc contributes to tumorigenesis", Nat Genet, 40, pp.43~50 (2008)[DOI]
11. Johnson CD, "The let-7 microRNA represses cell proliferation pathways in human cells", Cancer Res, 67, pp.7713~7722 (2007)[DOI]
12. Tsai WC, "MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis", J Clin Invest, 122, pp.2884~2897 (2012)[DOI]
13. Liu J, "MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA", Am J Cancer Res, 7, pp.148~158 (2017)
14. Zhang PF, "miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression", Oncotarget, 7, pp.35284~35292 (2016)
15. Hu F, "MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4", Biochem Biophys Res Commun, 474, pp.35~42 (2016)[DOI]
16. Zhang R, "MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer", Med Oncol, 31, pp.347~ (2014)[DOI]
17. Li Y, "Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer", Oncol Rep, 35, pp.1967~1978 (2016)[DOI]
18. Chen Y, "MicroRNA 363 mediated positive regulation of c-myc translation affect prostate cancer development and progress", Neoplasma, 62, pp.191~198 (2015)[DOI]
19. Conti A, "MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation", Tumour Biol, 37, pp.14035~14048 (2016)[DOI]
20. Lin Y, "MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1", Oncotarget, 8, pp.101649~101658 (2017)
21. Huang H, "LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363", J Cell Mol Med, 22, pp.3238~3245 (2018)[DOI]
22. Zhang P, "Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer", Cell Death Dis, 5, pp.e991~ (2014)[DOI]
23. Boyerinas B, "Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1", Int J Cancer, 130, pp.1787~1797 (2012)[DOI]
24. Chin LJ, "A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk", Cancer Res, 68, pp.8535~8540 (2008)[DOI]
25. Liu C, "Distinct microRNA expression profiles in prostate cancer stem", progenitor cells and tumor-suppressive functions of let-7, 2012, pp.72, 3393~3404
26. Yu F, "let-7 regulates self renewal and tumorigenicity of breast cancer cells", Cell, 131, pp.1109~1123 (2007)[DOI]
27. Cai J, "Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin", Oncogenesis, 2, pp.e75~ (2013)[DOI]
28. Hsu DS, "Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer", Clin Cancer Res, 16, pp.4561~4571 (2010)[DOI]
29. Kaufhold S, "Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention", J Exp Clin Cancer Res, 33, pp.62~ (2014)[DOI]
30. Haslehurst AM, "EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer", BMC Cancer, 12, pp.91~ (2012)[DOI]
31. Zhuo W, "Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK", mitochondrial pathway, 2008, pp.62, 8~14

관련 논문AI추천